Cargando…
P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)
BACKGROUND: Leishmaniasis is a parasitic disease caused by different species of Leishmania parasites with a wide range of clinical manifestations. Antimonial compounds such as meglumine antimoniate (glucantime) are the first line drugs for the treatment of leishmaniasis. However, according to report...
Autores principales: | SOLEIMANIFARD, Simindokht, ARJMAND, Reza, SABERI, Sedighe, KHAMESIPOUR, Ali, KAZEMI, Mohammad, SALEHI, Mansoor, AKBARI, Mojtaba, HEJAZI, SeyedHossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316575/ https://www.ncbi.nlm.nih.gov/pubmed/25678928 |
Ejemplares similares
-
Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
por: Soleimanifard, Simindokht, et al.
Publicado: (2017) -
In vivo/In vitro immune responses to L. major isolates from patients with no clinical response to Glucantime
por: Saberi, Sedigheh, et al.
Publicado: (2016) -
Fe3O4@Bio-MOF Nanoparticles Combined with Artemisinin, Glucantime®, or Shark Cartilage Extract on Iranian Strain of Leishmania major (MRHO/IR/75/ER): An In-Vitro and In-Vivo Study
por: GHAFARIFAR, Fatemeh, et al.
Publicado: (2020) -
In Vitro Study of the Leishmanicidal Activity of Perovskia Abrotanoides Terpenoid-Rich Fractions Against Leishmania Major (MRHO/IR/75/ER)
por: Dinani, Masoud Sadeghi, et al.
Publicado: (2023) -
Comparison of p27 Gene Expression of Promastigote and Amastigote Forms of Leishmania major (MRHO/IR/75/ER) by Real-time RT-PCR
por: ELIKAEE, Samira, et al.
Publicado: (2018)